Congenital Bands with Intestinal Malrotation after Propylthiouracil Exposure in Early Pregnancy

Alexander A Leung1, Jennifer Yamamoto1, Paola Luca2

  • 1Division of Endocrinology and Metabolism, Department of Medicine, University of Calgary, Calgary, AB, Canada T2T 5C7.

Insights

Propylthiouracil exposure during early pregnancy may increase birth defect risks. This case suggests a potential link between propylthiouracil and congenital bands causing intestinal issues.

Area of Science:

  • Perinatology
  • Developmental Biology
  • Pediatric Surgery

Background:

  • Propylthiouracil (PTU) is used to treat Graves' disease during pregnancy.
  • The full spectrum of PTU-associated birth defects remains unclear.
  • Previous reports linked PTU to preauricular and urinary system anomalies.

Purpose of the Study:

  • To investigate the potential association between first-trimester propylthiouracil exposure and congenital bands.
  • To highlight congenital bands as a possible rare teratogenic effect of PTU.

Main Methods:

  • Case report of a neonate with small bowel obstruction and intestinal malrotation.
  • Review of maternal medical history, including first-trimester propylthiouracil use for Graves' disease.
  • Analysis of the potential link between maternal PTU exposure and infant's congenital anomalies.

Main Results:

  • The patient presented with acute small bowel obstruction due to intestinal malrotation caused by congenital bands.
  • The mother used propylthiouracil in the first trimester for Graves' disease.
  • The case suggests a possible association between maternal PTU use and congenital bands with intestinal malrotation.

Conclusions:

  • Congenital bands may be a rare complication of early pregnancy propylthiouracil exposure.
  • This association warrants further investigation with more reported cases.
  • Early pregnancy PTU use requires careful consideration for potential teratogenic effects beyond known anomalies.